Category: Clinical Breakthroughs
-
Evaluating Treatment Options for Peripheral Artery Disease
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
-
Asian Americans’ Obesity Prevalence is not One-Size-Fits-All
There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.
-
Widespread Bias, Discrimination Directed Toward People With Disabilities Who Seek Healthcare
A new study shows physicians may be choosing to deny care to people with disabilities, and some use discretionary excuses to strategically discharge them from their practice.
-
First Drug to Reduce Risk of Mortality and Hospitalization in Heart Failure
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
-
Study Finds Biologic Drug ‘Highly Effective’ in Reducing Pediatric Eczema Symptoms
The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.
-
Improving Drug Therapy for Relapsed Leukemia
A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.
-
Survivors of Childhood Cancer Still at Risk for Infection Years After Diagnosis
After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.
-
Leading Translational Gastroenterology Research
Northwestern Memorial Hospital was recently ranked seventh in the country for Gastroenterology & Gastrointestinal (GI) surgery by US News and World Report. This article was originally published in August 2022 Breakthroughs.
-
Investigating the Utility of Polygenic Risk Scores for CHD
Polygenic risk scores demonstrated minimal clinical benefit in predicting long-term coronary heart disease when added to a traditional risk factor model, according to a Northwestern Medicine study.
-
Northwestern Awarded First-Ever National Grant to Study Wearables, Stroke Prevention in Patients With Atrial Fibrillation
Northwestern University has been awarded a seven-year grant to study a “pill-in-pocket” strategy to prevent stroke in patients with atrial fibrillation, the most common heart rhythm disorder in adults.
